Orthopedics , Trauma

Forearm Strangulation: An Interesting Cause of Compartment Syndrome

12/16/2019 Amy E. Mulcahy, PA-C, MS, PHPE , Brendan A. Mulcahy, DO, PHP, PA-C

Investigate the pressure of this tangled case of a patient with a limb-threatening injury at first discharged home in the absence of a fracture.

Toxicology , Recreational Drugs , Medications

GHB: A Forgotten Foe Rises

12/16/2019 Garrett Prince, MD , Max Ofoma , Daniel O. Bral, DO, MPH

The classic story of GHB intoxication you may see in your ED — “you are about to intubate a comatose patient and they wake up suddenly.” What next?

46-6 ventilator alarm iStock-108223034.jpg

Critical Care , Ventilator Management , Clinical

Your First Shift in the Unit: Demystifying Ventilator Alarms

12/16/2019 Marc Cassone, DO , Anthony Cocciolone, DO , Eric Melnychuk, DO

Ventilator alarms can be the first sign of an acute process and should be addressed immediately. It’s important to understand basic troubleshooting and move beyond DOPES when managing vent alarms.

EMRA Board of Directors

Meet Your EMRA Leadership

12/16/2019

The EMRA Representative Council elected the most diverse Board of Directors in the organization’s 45-year history this fall, setting a new bar for inclusion in medicine.

Informatics , Career Planning

Developing a Career in Clinical Informatics

12/16/2019 Benjamin Co , Christopher Libby, MD, MPH , John T. Finnell, MD, MSC, FACEP, FACMI

Indiana University's Clinical Informatics Fellowship Director John T. Finnell is ready to help solve the enigma about the confluence of the ED and IT.

Clinical , Airway , Ventilator Management

High Flow Nasal Cannula for the Emergency Physician

12/16/2019 Jason Block, MD

A look at this option for delivering supplemental oxygen in patients experiencing hypoxemic respiratory failure in emergency care.

Critical Care , Critical Care Alert

Critical Care Alert: CRASH-3 Review of TXA for TBI

12/16/2019 Ryan Lee, MD , Raymond Green, DO, FACS , Michael Perza, PharmD, BCPS

Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.